Latest News

I'm a title. ​Click here to edit me.


Scroll Down

Latest News

I'm a title. ​Click here to edit me.


Scroll Down

We were delighted that Aparito was selected as a winner of EIT Health’s Bridgehead Global 2020 programme. The press release is shown below:

Sun May 10 2020 23:00:00 GMT+0000 (Coordinated Universal Time)

In March, DHSC and MHCLG announced that funding would be available to innovators who can find digital ways to support people who need help during the coronavirus (COVID-19) outbreak.

Fri Apr 24 2020 01:30:00 GMT+0000 (Coordinated Universal Time)

Aparito is delighted to announce that we are joining the fight against #COVID19 using our flagship platform Atom5TM.

Thu Apr 09 2020 09:00:00 GMT+0000 (Coordinated Universal Time)

The COVID-19 outbreak may cause an unprecedented opportunity for the rare disease community in how we approach clinical trials.

Mon Mar 16 2020 13:30:00 GMT+0000 (Coordinated Universal Time)

Aparito, a company transforming healthcare by unlocking real-world patient data through mobile apps and wearable devices, and Pulse Infoframe, a leading cloud-based healthcare data insights company delivering a holistic solution to foster collaboration and answer complex research, statistical and economical questions have announced a strategic partnership in rare disease.

Mon Mar 16 2020 03:30:00 GMT+0000 (Coordinated Universal Time)

Aparito was interviewd as part of the GCRF Demonstrate Impact videos. You can find the final video at the link below:

Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Aparito: Transforming healthcare by unlocking real world patient data through mobile apps and wearable devices.

Wed Feb 19 2020 06:00:00 GMT+0000 (Coordinated Universal Time)

Daniel Lewi has joined Aparito as the new Business Development Manager and brings with him extensive experience in the rare disease space.  As the founder of the rare disease charity The Cure & Action for Tay-Sachs (CATS) Foundation, he is fully aware of the challenges that many families face when taking part in clinical trials whilst also juggling their day to day life.

Wed Jan 15 2020 16:30:00 GMT+0000 (Coordinated Universal Time)

The Sunday Times announced that Aparito has been chosen as one of Britain’s top 2019 start-up by the likes of Sir Richard Branson.

Mon Jan 06 2020 09:30:00 GMT+0000 (Coordinated Universal Time)

After two year of active recruitment by Principal Investigator Dr Karen Fieggen, University of Cape Town (UCT) and Clinical Co-Investigator Prof Jo Wilmshurst, of Red CrossChildren’s War Memorial Hospital in Cape Town, South Africa we are delighted to announce that this study using Aparito’s Atom5 platform is now completed.

Tue Dec 03 2019 12:10:00 GMT+0000 (Coordinated Universal Time)

These are the words from the Cure Sanfilippo Foundation. An advocacy group working to cure the disease.  Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is a rare autosomal recessive lysosomal storage disease that primarily affects the brain and spinal cord.

Sat Nov 16 2019 05:00:00 GMT+0000 (Coordinated Universal Time)

To mark our fifth year of operation we invited patients, health care professionals and researchers representing our therapeutic focus areas to share their experiences of working with the Aparito platform. We chose examples that would highlight Aparito’s patient focus, with stories of collaboration to deliver monitoring outside of the hospital (often remotely) using our ePRO modules.

Thu Sep 26 2019 21:30:00 GMT+0000 (Coordinated Universal Time)

Aparito is pleased to announce that Dr Anthony Hall MB, BS, BSc, AKC has been appointed to take on the role of Chief Medical Officer as of 24th July 2019.

Thu Sep 19 2019 00:30:00 GMT+0000 (Coordinated Universal Time)

Our Precision Medicine study in partnership with Red Cross Children’s War Memorial and University of Cape Town, South Africa is progressing well. Recruitment is now almost complete, and the majority of participants are engaging well with using the technology. Some challenges have been encountered, which is not unexpected when deploying innovative technology and supporting a cohort of families with limited resources whose children have multiple neurological disabilities, and whose care takes up a lot of time. This experience is invaluable, and as planned in this pilot study provides insight into the realities for future E-health initiatives for routine care and research in South Africa.

Fri Mar 08 2019 09:30:00 GMT+0000 (Coordinated Universal Time)

Aparito is pleased to announce that Cécile Ollivier has been appointed to take on the role of Chief Operating Officer as of 3rd December 2018.

Mon Nov 19 2018 10:30:00 GMT+0000 (Coordinated Universal Time)

The Red Cross War Memorial Children’s Hospital, Cape Town South Africa in partnership with Aparito, a Welsh based digital health company recruited their first patient in June following the successful deployment of Atom 5 – a software platform to enable next generation remote patient monitoring.

Thu Sep 13 2018 12:30:00 GMT+0000 (Coordinated Universal Time)

Aparito, the leading provider of remote patient monitoring and digital health technology supporting rare diseases, announces today the launch of its very latest build of its core product - Atom 5, Helium edition.

Fri Jun 15 2018 08:00:00 GMT+0000 (Coordinated Universal Time)

Monday 21 and Tuesday 22 May - Wales Millennium Centre, Cardiff Bay Dr Elin Haf Davies, CEO, aparito attended the festival which was organised by Innovation Point which is Wales’ innovation company.

Thu May 31 2018 16:00:00 GMT+0000 (Coordinated Universal Time)

Welsh health data company Aparito were represented at the UK wide AXA 2018 Health Tech & You awards ceremony held on the 9th May 2018 at the headquarters of the Royal College of General Practitioners in London. The company who were established in 2014 were joint winners of the Health Tech & You award for early diagnosis of dementia. Dr Elin Haf Davies, Aparito’s founder and Chief Executive Officer who hails from Bala but now lives in London, collected the award for the company’s proposal using a machine learning platform to monitor changes in sleep, activity, voice, ADL and memory collectively.

Thu May 31 2018 09:00:00 GMT+0000 (Coordinated Universal Time)

The Board is delighted to appoint Dr Hall as Chair. Following the success of closing an investment round earlier in the year, Aparito is delighted to welcome Dr Hall to the Board.

Thu Mar 29 2018 08:30:00 GMT+0000 (Coordinated Universal Time)

© 2019 by Aparito | Privacy Policy